Home Archive
Archive
2023 Volume 44 Issue 8  Published: 2023-08-10
    Topic
  • Changyuan LIU , Xin CHEN
    doi: 10.13683/j.wph.2023.08.001

    Now there is growing evidence supporting the association between hypertension and tumors, and the two diseases have some common epidemiological and pathophysiological characteristics. Although antineoplastic drugs greatly improve survival rate of cancer patients, they increase the risk of cardiovascular disease including cardiac disease, thrombotic disease and hypertension. Studies have confirmed that a variety of antineoplastic drugs can cause or worsen hypertension, which in turn is an associated risk factor for certain cancers (e.g., renal cell carcinoma, colorectal cancer). In addition, drug interactions and some other adjuvant drugs in tumor therapy also have the potential to elevate the risk of hypertension. In January 2023, the American Heart Association published a scientific statement on cancer therapy-related hypertension, which aims to elucidate the epidemiology of antineoplastic drugs, the possible mechanisms that cause hypertension, and the diagnosis and management of hypertension due to cancer therapy drugs, and to identify important issues that need to be addressed and to provide recommendations and guidance. This article interpreted this scientific statement and provides a reference for the clinical diagnosis and treatment of cancer therapy-related hypertension in China.

  • Topic
  • Shaokun XU , Jianhong XIE
    doi: 10.13683/j.wph.2023.08.002

    α-Receptor blockers are the classic drugs for hypertension, but they are no longer recommended as first-line antihypertensive agents in major hypertension guidelines. In recent years, with the continuous updating of relevant clinical trial results, the clinical application value of α-blockers has once again attracted attention, but its clinical application lacks sufficient and reasonable guidance, which hinders the important therapeutic effects of α-blockers. This article interpreted the recently published Chinese Expert Consensus on α-Blockers for Antihypertensive Therapy, in order to provide guidance for the rational application of α-receptor blockers.

  • Topic
  • Zekun FENG , Hao XUE
    doi: 10.13683/j.wph.2023.08.003

    Pregnancy-induced hypertension syndrome (PIH) is a group of diseases that coexist with pregnancy and hypertension, which is one of the main causes of mortality in pregnant women, fetuses, and newborns. According to most current guidelines, PIH is classified as mild and severe hypertension based on blood pressure levels. Consensus has been reached on the treatment of pregnant women with severe hypertension (blood pressure during pregnancy≥160/110 mmHg). However, the treatment of pregnant women with mild hypertension remains controversial. Previous views had suggested that treatment of mild hypertension reduced the risk of severe hypertension, but not the incidence of adverse outcomes such as preeclampsia, premature delivery and growth restriction. However, recent studies have shown that reducing the target blood pressure during pregnancy is not only safe, but also beneficial for patients. The guidelines also recommend the timing, goals, and lower safety limits for initiating antihypertensive therapy for PIH. This article overviewed the effects of PIH on mothers and offspring, reviewed the progress of blood pressure management in patients with PIH, emphasized the management strategies of pregnant women with mild hypertension, so as to provide a basis for the management of PIH.

  • Article
  • Boting CHEN , Xiaoyan GUO
    doi: 10.13683/j.wph.2023.08.004
    Objective

    To investigate the effect of mollugin on the biological behavior of human hepatocellular carcinoma cells and its mechanism.

    Methods

    HepG2 cells were divided into control group, low, medium and high concentration of mollugin (40, 60 and 80 mmol/L) group, SN50 (36 µmol/L) group and high concentration of mollugin (80 mmol/L)+LPS (2.5 µmol/L) group. Cell counting kit-8 assay, clonal formation assay, flow cytometry and Transwell staining were used to detect the proliferation, apoptosis, invasion and migration of HepG2 cells. Western blotting was used to detect the protein expression in HepG2 cells.

    Results

    Compared with the control group, the cell proliferation inhibition rate, apoptosis rate, rabbit anti-Caspase-3 (Caspase-3), B-cell lymphoma 2 associated X protein (Bax), inhibitor of nuclear factor-κB (IκB-α) and Bax/B-cell lymphoma 2 (Bcl-2) in the low, medium, and high concentration of mollugin groups and SN50 group were increased (P<0.05). The number of clone cells, invasion and migration cells, Bcl-2, matrix metalloproteinase (MMP)-2, MMP-9, nuclear factor (NF)-κB and p-IκB-α were all decreased (P<0.05). Compared with the high concentration of mollugin group, the cell proliferation inhibition rate, apoptosis rate, Caspase-3, Bax, IκB-α and Bax/Bcl-2 in high concentration of mollugin+LPS group were decreased, the number of cloned cells, invasive and migratory cells, and the expression of MMP-2, MMP-9, NF-κB, Bcl-2 and p-IκB-α were all increased (P<0.05).

    Conclusion

    Mollugin may inhibit cell proliferation, invasion, migration and promote apoptosis of HepG2 cells by inhibiting NF-κB pathway, which is expected to become a targeted drug for the treatment of liver cancer.

  • Article
  • Hui LI , Erhu LI , Shuqin LIU , Minmin Yin
    doi: 10.13683/j.wph.2023.08.005
    Objective

    To investigate the effects of Eupatilin on the migration and invasion of human cervical cancer (CC) cells and its regulation on Notch signaling pathway.

    Methods

    The Caski cells, a human CC intestinal metastasis cell line, were cultured and divided into blank control (BC) group, negative control (NC) group, Eupatilin group, Notch 1 overexpression (Notch 1) group, Eupatilin and Notch 1 overexpression (Eupatilin + Notch 1) group. MTT method was performed to measure the viability of cells. Scratch healing test and Transwell test were performed to measure the migration and invasion of cells. Western blot was performed to measure the levels of epithelial-mesenchymal transition (EMT) and Notch signaling pathway-related proteins in cells.

    Results

    Compare with the NC group, the cell viability, migration and invasion abilities, N-cadherin, Snail, Notch 1, Hes-1 and Hes-5 protein levels in Eupatilin group were decreased, and the E-cadherin protein level was increased (P<0.05). The changes of the above indexes in Notch 1 group were opposite to those in Eupatilin group (P<0.05). The overexpression of Notch 1 reversed the effects of Eupatilin on the viability, migration and invasion of Caski cells and the Notch signaling pathway (P<0.05).

    Conclusion

    Eupatilin inhibits the migration and invasion of human CC cells through Notch 1/Hes signaling pathway, which may provide some new clues for the clinical treatment of human CC.

  • Article
  • Xuehai GUO , Yongjian ZHANG , Xiufeng GAO , Hongyang ZHAO , Bin WANG
    doi: 10.13683/j.wph.2023.08.006
    Objective

    To investigate the effect of long non-coding (Lnc) RNA SNHG3 on malignant biological behavior of gastric cancer cells and its molecular mechanism.

    Methods

    Real-time quantitative polymerase chain reaction was used to detect LncRNA SNHG3 expression in normal gastric mucosal epithelial cells and gastric cancer cells. SNHG3 knockdown expression group and negative control group were constructed, and a blank control group was set up. Cell counting kit-8 assay, Transwell assay and flow cytometry were used to detect the effect of knockdown LncRNA SNHG3 expression on proliferation, migration, invasion and apoptosis of gastric cancer cells. The downstream target gene of LncRNA SNHG3 was predicted by the biological information website, and the binding relationship was verified by dual luciferase reporter experiments. Western blot was used to detect the effect of LncRNA SNHG3 on downstream target protein expression.

    Results

    The expression levels of LncRNA SNHG3 in gastric cancer cells HGC-27, MGC-803, MKN-45 and BGC-823 were significantly higher than those in normal gastric mucosal epithelial cells CES-1, and the differences were statistically significant (F=16.128, P<0.05). After knockdown SNHG3 expression, the proliferation, migration and invasion ability of gastric cancer cells were significantly reduced, and the proportion of apoptosis was significantly increased. LncRNA SNHG3 and Skp2 both had binding sites with micro RNA (miR)-340-5p, and miR-340-5p reduced the luciferase activity of WT-SNHG3 and WT-Skp2. LncRNA SNHG3 negatively regulated the miR-340-5p gene and further acted on the Skp2 protein.

    Conclusion

    LncRNA SNHG3 is highly expressed in gastric cancer cell lines, and down-regulation can inhibit the proliferation, migration and invasion of gastric cancer cells, induce apoptosis, which may play a role in regulating Skp2 expression by endogenously competing miR-340-5p.

  • Article
  • Kai TONG , Honglan LUO
    doi: 10.13683/j.wph.2023.08.007
    Objective

    To investigate the effects of lobaplatin on proliferation, apoptosis and migration of lung cancer cell A549 by regulating protein kinase R-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2α(eIF2α)/activating transcription factor 4 (ATF4)/CCAAT/enhancer binding protein homologous protein (CHOP) signaling pathway.

    Methods

    A549 cells were divided into control group, lobaplatin group (12 μmol/L lobaplatin), PERK inhibition group (5 μmol/L GSK2606414) and lobaplatin (12 μmol/L)+PERK inhibition group (5 μmol/L GSK2606414). MTT method, Transwell experiment and flow cytometry were used to detect cell proliferation, migration, invasion, and apoptosis. Western blot was used to detect the protein levels of PERK/eIF2α/ATF4/CHOP signaling pathway.

    Results

    Compared with the control group, the absorbance value, cell migration number and invasion number in lobaplatin group were decreased at 24 h and 48 h, and the apoptosis rate, phosphrylated-PERK/PERK, phosphrylated-eIF2α/eIF2α, ATF4 and CHOP protein levels were increased (P<0.01). The absorbance value, cell migration number and invasion number in PERK inhibited group were increased at 24 h and 48 h, and the protein levels related to PERK/eIF2α/ATF4/CHOP signaling pathway were decreased (P<0.01). Compared with lobaplatin group, the proliferation, migration and invasion numbers of A549 cells in lobaplatin+PERK inhibitory group were increased, and the apoptosis rate and the protein levels of PERK/eIF2α/ATF4/CHOP signaling pathway were decreased (P<0.01).

    Conclusion

    Lobaplatin may inhibit the proliferation, migration and invasion of A549 cells and promote cell apoptosis by activating the PERK/eIF2α/ATF4/CHOP pathway.

  • Article
  • Shuang FAN , Guoqi MAO , Fang LEI , Wujing SONG
    doi: 10.13683/j.wph.2023.08.008
    Objective

    To compare the effect of different doses of intravenous immunoglobulin (IVIG) combined with aspirin on helper T cell 17 (Th17)/regulatory T cell (Treg) cell imbalance in children with Kawasaki disease (KD).

    Methods

    A retrospective cohort study was conducted on 73 children with acute KD treated in our department of pediatrics from September 2016 to August 2020. They were divided into control group (n=35, IVIG 1 g/kg+aspirin) and observation group (n=38, IVIG 2 g/kg+aspirin), according to different doses of IVIG. Peripheral blood was collected before treatment and within 3 days after IVIG treatment, and the ratio of Th17/Treg cells, interleukin (IL)-17, IL-6, IL-23 and transforming growth factor (TGF)-β levels were detected.

    Results

    The time of fever reduction and the time of cervical non-pyulent lymph node detumescence in observation group were shorter than those in control group (P<0.05). Compared with before treatment, the proportion of Th17 cells, the ratio of Th17/Treg cells and serum levels of IL-17, IL-6 and IL-10 were decreased in both groups after treatment, while the level of TGF-β was increased (P<0.05). The changes of Th17 cell proportion, Th17/Treg cell ratio and serum IL-17 and IL-10 levels in observation group were significantly higher than those in control group (P<0.05).

    Conclusion

    Intravenous injection of high-dose IVIG combined with aspirin is effective in KD children. It can effectively improve the cell imbalance of Th17/Treg and immune dysfunction in acute KD children, and reduce the level of serum inflammatory factors, with good safety.

  • Article
  • Sheng ZHANG , Shunxiao ZHANG , Hua WANG , Yuanyuan LI , Yue CHEN
    doi: 10.13683/j.wph.2023.08.009
    Objective

    To observe the clinical effects of Jianpi Qinghua recipe combined with metformin in the treatment of type 2 diabetes mellitus (T2DM) patients with spleen deficiency and stomach heat syndrome.

    Methods

    A total of 94 overweight obese T2DM patients with spleen deficiency and stomach heat with poor control of metformin monotherapy were included in the endocrinology clinic of Shanghai Baoshan hospital of integrated traditional Chinese and western medicine from April 2021 to September 2022, and were randomly divided into treatment group (n=48, Jianpi Qinghua recipe+metformin) and control group (n=46, Jianpi Qinghua recipe placebo+metformin). All patients were treated for 12 weeks. The glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG) and 2-hour postprandial blood glucose (2hBG), fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triacylglycerol were compared and analyzed before and after the intervention.

    Results

    The compliance rates of HbA1c in the treatment group and the control group were 64.58% and 43.48%, with statistical significance respectively (P<0.05). After intervention, HbA1c, FBG, and 2hBG in the treatment group were lower than before intervention, and the difference were statistically significant (P<0.05), while there was no statistically significant difference in lipid metabolism indicators and HOMA-IR before and after intervention (P>0.05). There was no statistically significant difference in glucose and lipid metabolism indicators and HOMA-IR in control group before and after intervention (P>0.05).

    Conclusion

    Jianpi Qinghua recipe can improve glucose metabolism in overweight and obese T2DM patients with spleen deficiency and stomach heat. Combined use of metformin alone can be considered if the blood glucose control is not good.

  • Article
  • Xuting LIU , Shengnan GAO , Ran QI , Guoqiang LIU
    doi: 10.13683/j.wph.2023.08.010
    Objective

    To investigate the effects of Eupatilin on the migration and invasion of human cervical cancer (CC) cells and its regulation on Notch signaling pathway.

    Methods

    The Caski cells, a human CC intestinal metastasis cell line, were cultured and divided into blank control (BC) group, negative control (NC) group, Eupatilin group, Notch 1 overexpression (Notch 1) group, Eupatilin and Notch 1 overexpression (Eupatilin + Notch 1) group. MTT method was performed to measure the viability of cells. Scratch healing test and Transwell test were performed to measure the migration and invasion of cells. Western blot was performed to measure the levels of epithelial-mesenchymal transition (EMT) and Notch signaling pathway-related proteins in cells.

    Results

    Compare with the NC group, the cell viability, migration and invasion abilities, N-cadherin, Snail, Notch 1, Hes-1 and Hes-5 protein levels in Eupatilin group were decreased, and the E-cadherin protein level was increased (P<0.05). The changes of the above indexes in Notch 1 group were opposite to those in Eupatilin group (P<0.05). The overexpression of Notch 1 reversed the effects of Eupatilin on the viability, migration and invasion of Caski cells and the Notch signaling pathway (P<0.05).

    Conclusion

    Eupatilin inhibits the migration and invasion of human CC cells through Notch 1/Hes signaling pathway, which may provide some new clues for the clinical treatment of human CC.

  • Article
  • Fanli JIANG , Yongjun LIU , Yu QIU , Nannan LENG
    doi: 10.13683/j.wph.2023.08.011
    Objective

    To conduct pharmacoeconomic analysis of 5 liver protective drug injections commonly used in clinic.

    Methods

    From the perspective of China's health system, Markov model was constructed according to the characteristics of drug-induced liver injury disease. The cost-effectiveness of 5 hepatoprotective drugs, including compound glycyrrhizin glucoside, polyene phosphatidyl choline, magnesium isoglycyrrhizinate, diammonium glycyrrhizinate and reduced glutathione were analyzed, and sensitivity analysis was performed to verify the robustness of the results.

    Results

    For patients with drug-induced liver injury, diammonium glycyrrhizinate, polyene phosphatidyl choline and reduced glutathione are the absolute inferior treatment regimen compared with compound glycyrrhizin, while magnesium isoglycyrrhizinate is more effective and higher cost than compound glycyrrhizin, and its incremental cost effect ratio incremental cost effectiveness ratio=3 500.57/quality adjusted life year is far less than the threshold value (3 times China's GDP per capita), which is the optimal treatment. The sensitivity analysis results were consistent with the basic analysis results, and all parameters changes did not change the model results.

    Conclusion

    Magnesium isoglycyrrhizinate is the most economical treatment plan, it is suggested to use magnesium isoglycyrrhizinate in clinical hepatoprotective treatment, in order to improve the overall social benefit and promote the rational allocation of medical resources.

  • Article
  • Chuchu ZENG , Xiaoxia WANG
    doi: 10.13683/j.wph.2023.08.012
    Objective

    To explore the correlation between serum uric acid (SUA) and left ventricular hypertrophy (LVH) in patients with maintenance hemodialysis (MHD).

    Methods

    A total of 162 MHD patients in our hospital were selected, SUA level and related clinical indicators were measured, and left ventricular mass index (LVMI) was determined. All patients were divided into LVH group and non-LVH group according to the LVMI. The correlation between SUA and LVH was analyzed.

    Results

    Compared with non-LVH group, LVH group had higher SUA level, more historical cases of diabetes mellitus, and lower serum albumin and triglyceride levels than non-LVH group (P<0.05). Multivariate logistic regression analysis of LVH showed that SUA was still an independent risk factor for LVH in MHD patients after adjusting for cardiovascular risk factors (odds ratio=1.041, P=0.017).

    Conclusion

    There is a correlation between SUA and LVH in MHD patients. With the increase of SUA level, LVH degree increases significantly.

  • Review
  • Jing LI , Xiaotian XIE , Mingzhu GUI
    doi: 10.13683/j.wph.2023.08.013

    Iron deficiency (ID) and iron deficiency anemia (IDA) in children are significantly associated with recurrent respiratory tract infection (RRTI) in children. ID can not only lead to IDA, but also lead to immune deficiency or decline in children and induce RRTI. Based on the literature in the past five years, the epidemiology, pathogenesis and diagnosis and treatment standards of IDA and childhood ID were summarized briefly, as well as the correlation between IDA and RRTI in children, so as to provide a basis for effectively improving the quality of IDA and RRTI prevention and treatment in children.

  • Review
  • Xiaodi LU , Lei ZHANG , Lin DU , Weihua PAN , Wanqing LIAO
    doi: 10.13683/j.wph.2023.08.014

    Chronic mucocutaneous candidiasis (CMC) is characterized by repeated or persistent infections by Candida albicans of skin, nail and mucous membranes (such as mouth, esophagus and vagina). CMC cases are mostly sporadic and secondary to other diseases, such as T-cell immunodeficiency caused by human immunodeficiency virus infection, diabetes, receiving immunosuppressive therapy or steroid therapy, etc. Familial hereditary CMC is quite rare, and is caused by congenital immunodeficiency. In 2015, it was classified as primary immunodeficiency disease by the International Union of Immunological Societies Expert Committee. This article reviewed the mechanisms of congenital immune deficiency in CMC and various traditional or novel treatment based on them.

  • Review
  • Jingxue LIU , Jia YI , Deduo XU , Shengyan YANG , Xia TAO
    doi: 10.13683/j.wph.2023.08.015

    Multiple myeloma (MM) is a hematologic tumor resulting from the malignant proliferation of monoclonal plasma cells in the bone marrow. In recent years, the extensive application of proteasome inhibitor (PI), immunomodulators and autologous or allogeneic stem cell transplantation have significantly improved the remission rate, survival rate and prognosis of MM patients. Bortezomib (BTZ) is a PI, which is effective in the treatment of MM in clinical practice. This article reviewed the progress of BTZ-based treatment of MM, aiming to provide some reference for clinical use.

  • Review
  • Zhaoyang WU , Zhanjun LI , Wujun DONG
    doi: 10.13683/j.wph.2023.08.016

    Sulodexide has been used as an antithrombotic agent for more than 50 years. This article reviewed the mechanism of sulodexide in vascular endothelial protection, anti-thrombosis and anti-inflammation and its clinical application, discussed the role and theoretical basis of sulodexide in the treatment of corona virus disease 2019 (COVID-19), and summarized the preliminary results of clinical trials for COVID-19. Countermeasures were formulated according to the pathophysiological characteristics of covid-19 systemic inflammation and thrombosis. Sulodexide has been included in the latest guidelines for the treatment of COVID-19 by the International Society for Thrombosis and Hemostasis. Due to the unique pharmacological effects and advantages such as vascular endothelial protection and anti-inflammation, sulodexide will play an important role in combating with COVID-19.

  • Review
  • Tingting XUE , Congying LI , Fei WU , Hang ZHAO , Ying ZHANG , Chunjie GAO , Ying LUO , Le KUAI , Bin LI , Xin MA , Xiaojie DING
    doi: 10.13683/j.wph.2023.08.017

    Professor Li Bin's clinical experience and academic views on the combined treatment of atopic dermatitis (AD) in children are presented. Professor Li Bin highlights that AD in children is mixed with deficiency and excess, and the key pathogenesis is hyper-fire in the heart, deficiency in the lung and spleen, and disturbed mind and spirit. Syndrome differentiation emphasizes the combination of local and whole, distinguishing primary and secondary, and taking both symptoms and root causes into consideration. Internal and external treatment should be combined in the treatment of children with AD, especially external treatment. The prescription for internal use is based on the principle of “clearing heart fire, cultivating earth and generating gold”. The medicine is light and gentle, and the external use should focus on the local syndrome differentiation, prevention and treatment should be combined. Besides, professor Li is good at using medications that regulate the mind and emphasizes treating the body and mind together.

  • Pharmacy administration
  • Xuemei ZHEN , Wenqianzi YANG , Xueshan SUN , Hengjin DONG
    doi: 10.13683/j.wph.2023.08.018
  • Pharmacy administration
  • Lianghui TONG , Fan ZHANG , Tanlin SUN , Yangyang ZHANG , Zhijuan ZHANG , Ruilin SONG
    doi: 10.13683/j.wph.2023.08.019

    In recent years, China has carried out in-depth clinical trial supervision reform and established a clinical trial management system that is in line with international standards. However, a minority from the United States and other western countries still take the news reports voluntarily disclosed by Chinese media on the self-inspection & verification of clinical trials in 2016 as the basis, ignoring the achievements of China's drug regulatory reform, questioning the quality of existing pharmaceutical clinical trials in China, which has a negative affect the internationalization development of China's pharmaceutical innovation. This paper conducted an in-depth study on the work of launching background of the self-inspection & verification of clinical trial data in 2015 and the relevant data in the 2017 summary report, revealed the actual situation of the work at that time, analyzed the policy background behind the problems, and put forward policy recommendations to continue to optimize the management of pharmaceutical clinical trials.

News